Herceptin (trastuzumab) Intravenous Infusion

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) March 2016 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity Verify the pregnancy status of females of reproductive potential prior...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts